Proponents argue that limits reduce the risk of addiction, but are they keeping pharmacists from caring for their patients?
As the opioid crisis worsens, pharmacies, pharmaceutical manufacturers, and legislators are scrambling to help solve the problem. Recently, those efforts have focused on limiting opioid supplies.
But in the effort to prevent unnecessary medications, are pain patients getting left behind? Continue reading
Safety concerns with the Centers for Disease Control opioid calculator – by Jeffrey Fudin, Mena Raouf, Erica L Wegrzyn, Michael E Schatman
This is a scientific rebuttal to the CDC’s reliance on an opioid MME converter to standardize and regulate doses.
Morphine milligram equivalence (MME) and other comparable acronyms have been employed in federal pain guidelines and used by policy makers to limit opioid prescribing
Concerns about the inner workings of the U.S. Centers for Disease Control and Prevention (CDC) have been mounting in recent months amid disclosures of cozy corporate alliances.
Now a group of more than a dozen senior scientists have reportedly lodged an ethics complaint alleging the federal agency is being influenced by corporate and political interests in ways that short-change taxpayers.
Though this complaint isn’t related to the opioid guidelines, it shows the rot infesting the CDC which is subverting science and producing corrupted data and industry-influenced reports. Continue reading
Is Suicide a Consequence of the CDC Opioid Guideline? – Pain Medicine News – AUGUST 11, 2016 – By Lynn R. Webster, MD
The law of unintended consequences states that the actions of people, and especially of governments, always have effects that are unanticipated, as when legislation and regulation aimed at righting a problem go wrong in other ways
An example may be the guideline issued by the Centers for Disease Control and Prevention (CDC) discouraging the use of opioids in treating chronic pain, excluding cancer and end of life. (Unintended consequences. http://tinyurl.com/?8p8g)
The guideline was not intended to be mandatory;
Thank you, Maia, for bringing some our suffering to light, for making visible the “invisible epidemic“ of suicides due to chronic pain no longer being treated.
Jay Lawrence broke his back in a 1980s accident that ultimately triggered years of chronic pain, …
Unintended consequences of universal mindfulness training for schoolchildren – Coyne of the Realm – by James C Coyne November 16, 2016
The UK is following the U.S. lead in forcing their doctors to prescribe fewer opioids and send everyone to mindfulness training instead. Both governments have anointed “mindfulness” and/or “meditation” as the cure-all for both physical and mental problems.
It is becoming clear that increasing numbers of people are descending into addiction as a response to the chronic debt, unemployment, and pain brought on by the ruthless winner-take-all culture in both countries,
Instead of tackling the difficult task of easing regressive economic policies, putting in place a better social safety net, and repairing the broken medical system, various forms of “mindfulness” and/or “meditation” are currently being promoted for all unhappy citizens (not just those in pain). Continue reading
How the DEA Changed the Overdose Numbers — Pain News Network – October 25, 2017 By Pat Anson, Editor
The 2017 National Drug Threat Assessment (NDTA) has both good and bad news about the nation’s worsening overdose crisis. But like other federal agencies, the DEA has a disturbing tendency to massage statistics to make the role of opioid pain medication more significant than it actually is.
This is not the first time the DEA has lumped opioid pain relievers with other drugs. In the 2016 NDTA, the DEA combined opioids with anti-anxiety drugs, but not stimulants or steroids.
A year earlier, in the 2015 NDTA, prescription opioids were in a category all to themselves. The effect of these changing and broadening definitions is significant. Continue reading
Pain management, prescription opioid mortality, and the CDC: is the devil in the data? – Michael E Schatman, Stephen J Ziegler – Oct 2017
This article picks apart the data selected by the CDC to create the opioid prescribing guidelines.
These are excerpts from the full article:
Transparency, freedom from bias, and accountability are, in principle, hallmarks of taxpayer-funded institutions. Unfortunately, it seems that at least one institution, the Centers for Disease Control and Prevention (CDC), continues to struggle with all three. Continue reading
Increased use of heroin as an initiating opioid of abuse. – PubMed – NCBI – Addict Behav. 2017 Nov;
Note to CDC: data now clearly show that prescribed opioids are *not* the initiating drugs for addiction and fatal overdoses, so stop harassing pain patients!
Given the relatively recent growth in access to heroin and a more permissive atmosphere surrounding its use, we hypothesized that an increasing number of persons with limited experience and tolerance to opioids would experiment with heroin as their first opioid rather than more common prescription opioid analgesics.
Spoiler alert: their hypothesis was proven true. Continue reading
Public-Health Experts Are Skeptical of the CDC’s New Anti-Opioid Campaign – Pacific Standard – Oct 2017
Last month, the Centers for Disease Control and Prevention (CDC) launched an advertising campaign aimed at reducing addictions and deaths that are linked to prescription opioids.
The campaign suggests the government wants Americans to eschew opioid prescriptions altogether. Its tagline is, “It only takes a little to lose a lot.”
In his featured ad, Duggan says, “One prescription can be all it takes to lose everything.“
This is the biggest lie of all because addiction is in the person, not the drug. Continue reading